▶ 調査レポート

世界のカポジ肉腫診断市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Kaposi Sarcoma Diagnosis Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のカポジ肉腫診断市場規模・現状・予測(2021年-2027年) / Global Kaposi Sarcoma Diagnosis Market Size, Status and Forecast 2021-2027 / QFJ1-4401資料のイメージです。• レポートコード:QFJ1-4401
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、カポジ肉腫診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(生検、イメージング)、用途別市場規模(病院、診断センター、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・カポジ肉腫診断の市場動向
・企業の競争状況、市場シェア
・カポジ肉腫診断の種類別市場規模と予測2016-2027(生検、イメージング)
・カポジ肉腫診断の用途別市場規模と予測2016-2027(病院、診断センター、クリニック、その他)
・カポジ肉腫診断の北米市場規模2016-2027(アメリカ、カナダ)
・カポジ肉腫診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・カポジ肉腫診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・カポジ肉腫診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・カポジ肉腫診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Navidea Biopharmaceuticals, Inc、Quest Diagnostics、Cleveland Clinic、LightDeck Diagnostics、Mayo Foundation for Medical Education and Research (MFMER)、Massachusetts General Hospital、UCLA Health、The Johns Hopkins Hospital、NYU Langone Hospitals、The Ohio State University Comprehensive Cancer Center、Memorial Sloan Kettering Cancer Center)
・結論

Kaposi sarcoma cancer is a type of soft tissue cancer. Kaposi sarcoma is a group of cancer that starts in the tissue that supports and connects the body. Kaposi sarcoma cancer generally located below the skins surface or in the lining of the nose and mouth. Kaposi sarcoma cancer is basically caused by the virus known as human herpesvirus 8 or Kaposi’s sarcoma-associated herpesvirus. The main symptoms of Kaposi sarcoma is skin lesions. These lesions are usually purple or red in color and look like bruises, which in overtime grow into lumps. Kaposi sarcoma is a rare type of cancer observed in people with AIDS. Kaposi sarcoma affects men more than women. There are several types of Kaposi sarcoma such as AIDS related Kaposi sarcoma which generally occur in homosexual men rather than others who contracted HIV through intravenous drug. Second is the classic Kaposi sarcoma which develops in older men. It typically appears first on legs and then on feet. It also affects the gastrointestinal tract and lining of the mouth.

Market Analysis and Insights: Global Kaposi Sarcoma Diagnosis Market
The global Kaposi Sarcoma Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kaposi Sarcoma Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kaposi Sarcoma Diagnosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kaposi Sarcoma Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kaposi Sarcoma Diagnosis market.

Global Kaposi Sarcoma Diagnosis Scope and Market Size
Kaposi Sarcoma Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kaposi Sarcoma Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biopsy
Imaging

Segment by Application
Hospital
Diagnostic centers
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Navidea Biopharmaceuticals, Inc
Quest Diagnostics
Cleveland Clinic
LightDeck Diagnostics
Mayo Foundation for Medical Education and Research (MFMER)
Massachusetts General Hospital
UCLA Health
The Johns Hopkins Hospital
NYU Langone Hospitals
The Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kaposi Sarcoma Diagnosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biopsy
1.2.3 Imaging
1.3 Market by Application
1.3.1 Global Kaposi Sarcoma Diagnosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Kaposi Sarcoma Diagnosis Market Perspective (2016-2027)
2.2 Kaposi Sarcoma Diagnosis Growth Trends by Regions
2.2.1 Kaposi Sarcoma Diagnosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kaposi Sarcoma Diagnosis Historic Market Share by Regions (2016-2021)
2.2.3 Kaposi Sarcoma Diagnosis Forecasted Market Size by Regions (2022-2027)
2.3 Kaposi Sarcoma Diagnosis Industry Dynamic
2.3.1 Kaposi Sarcoma Diagnosis Market Trends
2.3.2 Kaposi Sarcoma Diagnosis Market Drivers
2.3.3 Kaposi Sarcoma Diagnosis Market Challenges
2.3.4 Kaposi Sarcoma Diagnosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Kaposi Sarcoma Diagnosis Players by Revenue
3.1.1 Global Top Kaposi Sarcoma Diagnosis Players by Revenue (2016-2021)
3.1.2 Global Kaposi Sarcoma Diagnosis Revenue Market Share by Players (2016-2021)
3.2 Global Kaposi Sarcoma Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kaposi Sarcoma Diagnosis Revenue
3.4 Global Kaposi Sarcoma Diagnosis Market Concentration Ratio
3.4.1 Global Kaposi Sarcoma Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kaposi Sarcoma Diagnosis Revenue in 2020
3.5 Kaposi Sarcoma Diagnosis Key Players Head office and Area Served
3.6 Key Players Kaposi Sarcoma Diagnosis Product Solution and Service
3.7 Date of Enter into Kaposi Sarcoma Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Kaposi Sarcoma Diagnosis Breakdown Data by Type
4.1 Global Kaposi Sarcoma Diagnosis Historic Market Size by Type (2016-2021)
4.2 Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Type (2022-2027)

5 Kaposi Sarcoma Diagnosis Breakdown Data by Application
5.1 Global Kaposi Sarcoma Diagnosis Historic Market Size by Application (2016-2021)
5.2 Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Kaposi Sarcoma Diagnosis Market Size (2016-2027)
6.2 North America Kaposi Sarcoma Diagnosis Market Size by Type
6.2.1 North America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
6.2.2 North America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
6.2.3 North America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
6.3 North America Kaposi Sarcoma Diagnosis Market Size by Application
6.3.1 North America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
6.3.2 North America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
6.3.3 North America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
6.4 North America Kaposi Sarcoma Diagnosis Market Size by Country
6.4.1 North America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
6.4.2 North America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Kaposi Sarcoma Diagnosis Market Size (2016-2027)
7.2 Europe Kaposi Sarcoma Diagnosis Market Size by Type
7.2.1 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
7.2.2 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
7.2.3 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
7.3 Europe Kaposi Sarcoma Diagnosis Market Size by Application
7.3.1 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
7.3.2 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
7.3.3 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
7.4 Europe Kaposi Sarcoma Diagnosis Market Size by Country
7.4.1 Europe Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
7.4.2 Europe Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size (2016-2027)
8.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type
8.2.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application
8.3.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region
8.4.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Kaposi Sarcoma Diagnosis Market Size (2016-2027)
9.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Type
9.2.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
9.2.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
9.2.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
9.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Application
9.3.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
9.3.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
9.3.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
9.4 Latin America Kaposi Sarcoma Diagnosis Market Size by Country
9.4.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
9.4.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size (2016-2027)
10.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type
10.2.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application
10.3.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country
10.4.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Navidea Biopharmaceuticals, Inc
11.1.1 Navidea Biopharmaceuticals, Inc Company Details
11.1.2 Navidea Biopharmaceuticals, Inc Business Overview
11.1.3 Navidea Biopharmaceuticals, Inc Kaposi Sarcoma Diagnosis Introduction
11.1.4 Navidea Biopharmaceuticals, Inc Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.1.5 Navidea Biopharmaceuticals, Inc Recent Development
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Kaposi Sarcoma Diagnosis Introduction
11.2.4 Quest Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.2.5 Quest Diagnostics Recent Development
11.3 Cleveland Clinic
11.3.1 Cleveland Clinic Company Details
11.3.2 Cleveland Clinic Business Overview
11.3.3 Cleveland Clinic Kaposi Sarcoma Diagnosis Introduction
11.3.4 Cleveland Clinic Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.3.5 Cleveland Clinic Recent Development
11.4 LightDeck Diagnostics
11.4.1 LightDeck Diagnostics Company Details
11.4.2 LightDeck Diagnostics Business Overview
11.4.3 LightDeck Diagnostics Kaposi Sarcoma Diagnosis Introduction
11.4.4 LightDeck Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.4.5 LightDeck Diagnostics Recent Development
11.5 Mayo Foundation for Medical Education and Research (MFMER)
11.5.1 Mayo Foundation for Medical Education and Research (MFMER) Company Details
11.5.2 Mayo Foundation for Medical Education and Research (MFMER) Business Overview
11.5.3 Mayo Foundation for Medical Education and Research (MFMER) Kaposi Sarcoma Diagnosis Introduction
11.5.4 Mayo Foundation for Medical Education and Research (MFMER) Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.5.5 Mayo Foundation for Medical Education and Research (MFMER) Recent Development
11.6 Massachusetts General Hospital
11.6.1 Massachusetts General Hospital Company Details
11.6.2 Massachusetts General Hospital Business Overview
11.6.3 Massachusetts General Hospital Kaposi Sarcoma Diagnosis Introduction
11.6.4 Massachusetts General Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.6.5 Massachusetts General Hospital Recent Development
11.7 UCLA Health
11.7.1 UCLA Health Company Details
11.7.2 UCLA Health Business Overview
11.7.3 UCLA Health Kaposi Sarcoma Diagnosis Introduction
11.7.4 UCLA Health Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.7.5 UCLA Health Recent Development
11.8 The Johns Hopkins Hospital
11.8.1 The Johns Hopkins Hospital Company Details
11.8.2 The Johns Hopkins Hospital Business Overview
11.8.3 The Johns Hopkins Hospital Kaposi Sarcoma Diagnosis Introduction
11.8.4 The Johns Hopkins Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.8.5 The Johns Hopkins Hospital Recent Development
11.9 NYU Langone Hospitals
11.9.1 NYU Langone Hospitals Company Details
11.9.2 NYU Langone Hospitals Business Overview
11.9.3 NYU Langone Hospitals Kaposi Sarcoma Diagnosis Introduction
11.9.4 NYU Langone Hospitals Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.9.5 NYU Langone Hospitals Recent Development
11.10 The Ohio State University Comprehensive Cancer Center
11.10.1 The Ohio State University Comprehensive Cancer Center Company Details
11.10.2 The Ohio State University Comprehensive Cancer Center Business Overview
11.10.3 The Ohio State University Comprehensive Cancer Center Kaposi Sarcoma Diagnosis Introduction
11.10.4 The Ohio State University Comprehensive Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.10.5 The Ohio State University Comprehensive Cancer Center Recent Development
11.11 Memorial Sloan Kettering Cancer Center
11.11.1 Memorial Sloan Kettering Cancer Center Company Details
11.11.2 Memorial Sloan Kettering Cancer Center Business Overview
11.11.3 Memorial Sloan Kettering Cancer Center Kaposi Sarcoma Diagnosis Introduction
11.11.4 Memorial Sloan Kettering Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.11.5 Memorial Sloan Kettering Cancer Center Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Kaposi Sarcoma Diagnosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biopsy
Table 3. Key Players of Imaging
Table 4. Global Kaposi Sarcoma Diagnosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Kaposi Sarcoma Diagnosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Kaposi Sarcoma Diagnosis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Kaposi Sarcoma Diagnosis Market Share by Regions (2016-2021)
Table 8. Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Kaposi Sarcoma Diagnosis Market Share by Regions (2022-2027)
Table 10. Kaposi Sarcoma Diagnosis Market Trends
Table 11. Kaposi Sarcoma Diagnosis Market Drivers
Table 12. Kaposi Sarcoma Diagnosis Market Challenges
Table 13. Kaposi Sarcoma Diagnosis Market Restraints
Table 14. Global Kaposi Sarcoma Diagnosis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Kaposi Sarcoma Diagnosis Market Share by Players (2016-2021)
Table 16. Global Top Kaposi Sarcoma Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma Diagnosis as of 2020)
Table 17. Ranking of Global Top Kaposi Sarcoma Diagnosis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Kaposi Sarcoma Diagnosis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Kaposi Sarcoma Diagnosis Product Solution and Service
Table 21. Date of Enter into Kaposi Sarcoma Diagnosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Type (2016-2021)
Table 25. Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Kaposi Sarcoma Diagnosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Application (2016-2021)
Table 29. Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Navidea Biopharmaceuticals, Inc Company Details
Table 62. Navidea Biopharmaceuticals, Inc Business Overview
Table 63. Navidea Biopharmaceuticals, Inc Kaposi Sarcoma Diagnosis Product
Table 64. Navidea Biopharmaceuticals, Inc Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 65. Navidea Biopharmaceuticals, Inc Recent Development
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Kaposi Sarcoma Diagnosis Product
Table 69. Quest Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 70. Quest Diagnostics Recent Development
Table 71. Cleveland Clinic Company Details
Table 72. Cleveland Clinic Business Overview
Table 73. Cleveland Clinic Kaposi Sarcoma Diagnosis Product
Table 74. Cleveland Clinic Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 75. Cleveland Clinic Recent Development
Table 76. LightDeck Diagnostics Company Details
Table 77. LightDeck Diagnostics Business Overview
Table 78. LightDeck Diagnostics Kaposi Sarcoma Diagnosis Product
Table 79. LightDeck Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 80. LightDeck Diagnostics Recent Development
Table 81. Mayo Foundation for Medical Education and Research (MFMER) Company Details
Table 82. Mayo Foundation for Medical Education and Research (MFMER) Business Overview
Table 83. Mayo Foundation for Medical Education and Research (MFMER) Kaposi Sarcoma Diagnosis Product
Table 84. Mayo Foundation for Medical Education and Research (MFMER) Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 85. Mayo Foundation for Medical Education and Research (MFMER) Recent Development
Table 86. Massachusetts General Hospital Company Details
Table 87. Massachusetts General Hospital Business Overview
Table 88. Massachusetts General Hospital Kaposi Sarcoma Diagnosis Product
Table 89. Massachusetts General Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 90. Massachusetts General Hospital Recent Development
Table 91. UCLA Health Company Details
Table 92. UCLA Health Business Overview
Table 93. UCLA Health Kaposi Sarcoma Diagnosis Product
Table 94. UCLA Health Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 95. UCLA Health Recent Development
Table 96. The Johns Hopkins Hospital Company Details
Table 97. The Johns Hopkins Hospital Business Overview
Table 98. The Johns Hopkins Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 99. The Johns Hopkins Hospital Recent Development
Table 100. NYU Langone Hospitals Company Details
Table 101. NYU Langone Hospitals Business Overview
Table 102. NYU Langone Hospitals Kaposi Sarcoma Diagnosis Product
Table 103. NYU Langone Hospitals Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 104. NYU Langone Hospitals Recent Development
Table 105. The Ohio State University Comprehensive Cancer Center Company Details
Table 106. The Ohio State University Comprehensive Cancer Center Business Overview
Table 107. The Ohio State University Comprehensive Cancer Center Kaposi Sarcoma Diagnosis Product
Table 108. The Ohio State University Comprehensive Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 109. The Ohio State University Comprehensive Cancer Center Recent Development
Table 110. Memorial Sloan Kettering Cancer Center Company Details
Table 111. Memorial Sloan Kettering Cancer Center Business Overview
Table 112. Memorial Sloan Kettering Cancer Center Kaposi Sarcoma Diagnosis Product
Table 113. Memorial Sloan Kettering Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021) & (US$ Million)
Table 114. Memorial Sloan Kettering Cancer Center Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kaposi Sarcoma Diagnosis Market Share by Type: 2020 VS 2027
Figure 2. Biopsy Features
Figure 3. Imaging Features
Figure 4. Global Kaposi Sarcoma Diagnosis Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Diagnostic centers Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Kaposi Sarcoma Diagnosis Report Years Considered
Figure 10. Global Kaposi Sarcoma Diagnosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Kaposi Sarcoma Diagnosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Kaposi Sarcoma Diagnosis Market Share by Regions: 2020 VS 2027
Figure 13. Global Kaposi Sarcoma Diagnosis Market Share by Regions (2022-2027)
Figure 14. Global Kaposi Sarcoma Diagnosis Market Share by Players in 2020
Figure 15. Global Top Kaposi Sarcoma Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma Diagnosis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Kaposi Sarcoma Diagnosis Revenue in 2020
Figure 17. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Type (2016-2021)
Figure 18. Global Kaposi Sarcoma Diagnosis Revenue Market Share by Type (2022-2027)
Figure 19. North America Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Kaposi Sarcoma Diagnosis Market Share by Type (2016-2027)
Figure 21. North America Kaposi Sarcoma Diagnosis Market Share by Application (2016-2027)
Figure 22. North America Kaposi Sarcoma Diagnosis Market Share by Country (2016-2027)
Figure 23. United States Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Kaposi Sarcoma Diagnosis Market Share by Type (2016-2027)
Figure 27. Europe Kaposi Sarcoma Diagnosis Market Share by Application (2016-2027)
Figure 28. Europe Kaposi Sarcoma Diagnosis Market Share by Country (2016-2027)
Figure 29. Germany Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Kaposi Sarcoma Diagnosis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Kaposi Sarcoma Diagnosis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Kaposi Sarcoma Diagnosis Market Share by Region (2016-2027)
Figure 39. China Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Kaposi Sarcoma Diagnosis Market Share by Type (2016-2027)
Figure 47. Latin America Kaposi Sarcoma Diagnosis Market Share by Application (2016-2027)
Figure 48. Latin America Kaposi Sarcoma Diagnosis Market Share by Country (2016-2027)
Figure 49. Mexico Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Kaposi Sarcoma Diagnosis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Kaposi Sarcoma Diagnosis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Kaposi Sarcoma Diagnosis Market Share by Country (2016-2027)
Figure 55. Turkey Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Kaposi Sarcoma Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Navidea Biopharmaceuticals, Inc Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 59. Quest Diagnostics Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 60. Cleveland Clinic Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 61. LightDeck Diagnostics Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 62. Mayo Foundation for Medical Education and Research (MFMER) Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 63. Massachusetts General Hospital Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 64. UCLA Health Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 65. The Johns Hopkins Hospital Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 66. NYU Langone Hospitals Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 67. The Ohio State University Comprehensive Cancer Center Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 68. Memorial Sloan Kettering Cancer Center Revenue Growth Rate in Kaposi Sarcoma Diagnosis Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed